Showing results (191-200 of 239) with videos related to

Sort By:
Pageof 24
Leukemia Research|April 26, 2016
MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletionMaría Hernández-Sánchez, Ana E Rodríguez-Vicente, José-Ángel Hernández, et al.
Cancers|June 10, 2023
Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in SpainJavier de la Rubia, Rafael Alonso, María Esther Clavero, et al.
Acta Otorrinolaringologica Espanola|August 28, 2022
Usefulness of endonasal flaps and grafts in skull base surgery. Consensus documentRamón Moreno-Luna, Franklin Mariño Sánchez, Ariel Kaen, et al.
Blood|January 27, 2011
The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosisBruno Paiva, María-Belén Vídriales, José J Pérez, et al.
Acta Otorrinolaringologica Espanola|July 31, 2021
Usefulness of endonasal flaps and grafts in skull base surgery. Consensus documentRamón Moreno-Luna, Franklin Mariño Sánchez, Ariel Kaen, et al.
BMC Cancer|February 7, 2020
Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumorsCésar Serrano, Ana Vivancos, Antonio López-Pousa, et al.
Haematologica|February 6, 2010
Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patientsMaría Carmen Chillón, Carlos Santamaría, Ramón García-Sanz, et al.
Haematologica|March 3, 2009
A high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemiaJosé Angel Hernández, Ana Eugenia Rodríguez, Marcos González, et al.
Haematologica|January 28, 2017
Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myelomaVerónica González-Calle, Seila Cerdá, Jorge Labrador, et al.
British Journal of Haematology|November 17, 2015
The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximabMaribel Forero-Castro, Cristina Robledo, Eva Lumbreras, et al.
Pageof 24